References
- Burchenal, J. H. , Johnston, S. F. , Cremer, M. , Webber, I. F. and Stock, C. C. (1950) The action of certain ethylenimine (Aziridine) derivatives on mouse leukemia. Arch. Biochem, 26, p. 321.
- Burchenal, J. H. , Johnston, S. F. , Stock, C. C. , Crossley, M. L. and Rhoads, C. P. (1950) The effect of 2, 4, 6-triethyleneimino-s-triazine and related compounds on transplanted mouse leukemia. Cancer Research, 10, p. 208.
- Karnofsky, D. A. , Burchenal, J. H. , Armistead Jr, G. C. , Southam, C. M. , Bernstein, J. L. , Craver, L. F. and Rhoads, C. P. (1951) Triethylene melamine in the treatment of neoplastic disease. Arch. Int. Med, 87, p. 477.
- Lewis, M. R. and Crossley, M. L. (1950) Retardation of tumor growth in mice by oral administration of ethylenimine derivatives. Arch. Biochem, 26, p. 319.
- Paterson, Edith and Boland, J. (1951) Trisethyleneimino-s-triazine in human malignant disease: A preliminary trial. Brit. J. Cancer, 5, p. 28.
- Philips, F. S. and Thiersch, J. B. (1950) The nitrogen mustard-like actions of certain ethylenimines: I. 2, 4, 6-tris (ethylenimino)-S-triazine and analogs. J. Pharmacol. & Exper. Therap, 100, p. 398.
- Rhoads, C. P. , Karnofsky, D. A. , Burchenal, J. H. and Craver, L. F. (1950) Triethylene melamine in the treatment of Hodgkin's disease and allied neoplasms. Tr. A. Am. Physicians, 63, p. 136.
- Rose, F. L. , Hendry, J. A. and Walpole, A. L. (1950) New cytotoxic agents with tumour-inhibitory activity. Nature, 165, p. 993.
- Wright, L. T. , Wright, Jane C. , Prigot, Aa. and Weintraub, S. (1950) Triethylene melamine therapy in Hodgkin's disease and allied neoplastic diseases. J. Nat. M.A., 42, p. 343.